Clinical Trial Update: Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy [Phase 2]

View source ↗

Summary

Phase 2 study conducted in Japan evaluating safety and antiviral activity of lamivudine in adults with chronic hepatitis B who are on lamivudine therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Epivir-HBV (lamivudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED